false
0000914139
0000914139
2026-08-06
2026-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 6, 2026
PARKERVISION, INC.
(Exact Name of Registrant as Specified in Charter)
| |
|
|
|
Florida
|
000-22904
|
59-2971472
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
| |
|
|
4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida
|
32207
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
(904) 732-6100
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| |
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| |
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of Each Class
|
Trading Symbol
|
Name of Each Exchange on Which Registered
|
|
None
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On August 6, 2026, ParkerVision, Inc. (the “Company”) issued a press release which reported financial and operating results for the six months ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
The information contained in this Current Report on Form 8-K, including Exhibit 99.1 hereto, has been “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
| Exhibit |
Description |
| 99.1 |
Press Release |
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
Dated: August 6, 2026
|
|
|
| |
|
PARKERVISION, INC.
|
| |
|
|
| |
|
By /s/ Cynthia French
|
| |
|
Cynthia French
|
| |
|
Chief Financial Officer
|
Exhibit 99.1
ParkerVision Reports Second Quarter 2026 Results
JACKSONVILLE, Fla., August 6, 2026 – ParkerVision, Inc. (OTCQB: PRKR) (“ParkerVision” or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the six months ended June 30, 2026.
2026 Summary and Recent Developments
| |
• |
Oral argument was held on June 1, 2026 in the Company's expedited appeal of ParkerVision v. Qualcomm (CAFC case no. 26-1033). The appellate court's decision has not yet been issued.
|
| |
|
|
| |
|
|
◦ |
The Company appealed the May 30, 2025 claim construction ruling made by the district court (Middle District of Florida) which led to a stipulation of noninfringement of the Company's receiver patent claims. The district court severed and stayed the remaining transmitter patent claims in the case pending the decision of the appellate court. |
| |
|
|
|
| |
|
|
◦ |
The briefings to the CAFC and the oral argument on June 1, 2026 addressed the merits of the appeal, the Company's request for the case to be assigned to a new judge, and Qualcomm's motion to dismiss for improper jurisdiction. |
| |
• |
The Company has submitted supplemental expert reports in both its MediaTek and Realtek cases that are pending in the Western District of Texas. New trial dates have not yet been established. |
| |
|
|
| |
|
|
◦ |
Judge Albright, the district court judge handling all of the Company's Texas actions, announced his retirement from the bench effective August 31, 2026, requiring reassignment of the Company's Texas infringement cases. |
| |
|
|
|
|
Jeffrey Parker, CEO of ParkerVision, commented, “We currently find ourselves in a 'hurry up and wait' period as we await a decision from the Federal Circuit on our Qualcomm appeal and revised scheduling orders from the western district of Texas as a result of Judge Albright’s imminent retirement from the bench and the assignment of our cases to a new judge. While we are anxious to get through these delays, we remain confident on the merits of our cases and enthusiastic to get these cases to jury trials.”
Financial Results
| |
•
|
ParkerVision reported a net loss for the six months ended June 30, 2026 of $1.4 million, or $0.01 per common share, compared to a net loss of $5.4 million, or $0.05 per common share for the six months ended June 30, 2025.
|
| |
◦ |
The decrease in net loss is the result of a $2.6 million decrease in operating expenses and a $1.5 million change in the fair value of the Company's contingent payment obligations.
- Operating expenses for the six months ended June 30, 2026, when compared to the same period in 2025, decreased by $1.9 million from decreases in share-based compensation expense and by $0.8 million from decreases in outside professional fees, including consulting, business advisory and litigation-related costs.
- The decrease in fair value of the Company's contingent payment obligations is primarily the result of changes in timing of patent infringement actions and changes in the risk-free rates of return used in the calculation of present value, somewhat offset by increasing accrued interest on the Company's secured contingent payment obligation.
|
| |
•
|
The Company used approximately $1.7 million in cash for operations for the first half of 2026 and ended the quarter with $2.5 million in cash and cash equivalents.
|
About ParkerVision
ParkerVision, Inc. invents, develops and licenses cutting-edge, proprietary radio-frequency (RF) technologies that enable wireless solution providers to make and sell advanced wireless communication products. ParkerVision is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are broadly infringed by others. For more information, please visit www.parkervision.com. (PRKR-I)
Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements regarding the timing, scheduling, and expected outcomes of current and future legal proceedings, the Company's expectations regarding such proceedings, and expectations concerning court rulings and trial dates. Forward-looking statements also include estimates and assumptions underlying financial information, including the fair value of contingent payment obligations and the Company’s ability to support ongoing operations and litigation.
These statements are based on current expectations, estimates, projections, and assumptions as of the date of this release, and involve known and unknown risks and uncertainties that could cause actual results to differ materially. Words such as “believe,” “optimistic,” “expect,” “will," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements include these words. Risks and uncertainties that may cause actual results to differ include, among others: adverse developments or delays in legal proceedings, including changes in litigation schedules; unfavorable court decisions or rulings; the loss or unavailability of key expert witnesses; the availability of funding for continued operations and litigation; changes in the legal or regulatory environment; inaccuracies in financial estimates or assumptions; and risks disclosed in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent filings.
Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.
|
|
|
Cindy French
|
|
Chief Financial Officer
|
|
ParkerVision, Inc
|
|
cfrench@parkervision.com
|
|
|
(TABLES FOLLOW)
ParkerVision, Inc.
Balance Sheet Highlights
| |
|
(unaudited)
|
|
|
|
|
|
|
(in thousands)
|
|
June 30, 2026
|
|
|
December 31, 2025
|
|
|
Cash and cash equivalents
|
|
$ |
2,501 |
|
|
$ |
4,360 |
|
|
Prepaid expenses and other current assets
|
|
|
557 |
|
|
|
304 |
|
|
Intangible assets & other noncurrent assets
|
|
|
623 |
|
|
|
695 |
|
|
Total assets
|
|
|
3,681 |
|
|
|
5,359 |
|
| |
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
2,270 |
|
|
|
2,409 |
|
|
Contingent payment obligations
|
|
|
44,763 |
|
|
|
46,089 |
|
|
Convertible notes, net of current portion
|
|
|
1,258 |
|
|
|
1,908 |
|
|
Other long-term liabilities
|
|
|
- |
|
|
|
57 |
|
|
Shareholders’ deficit
|
|
|
(44,610 |
) |
|
|
(45,104 |
) |
|
Total liabilities and shareholders’ deficit
|
|
$ |
3,681 |
|
|
$ |
5,359 |
|
ParkerVision, Inc.
Summary Results of Operations (unaudited)
| |
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
(in thousands, except per share amounts)
|
|
June 30,
|
|
|
June 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Licensing revenue
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
Cost of sales
|
|
|
(35 |
) |
|
|
(51 |
) |
|
|
(71 |
) |
|
|
(106 |
) |
|
Gross margin
|
|
|
(35 |
) |
|
|
(51 |
) |
|
|
(71 |
) |
|
|
(106 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
1,514 |
|
|
|
3,843 |
|
|
|
2,472 |
|
|
|
5,086 |
|
|
Total operating expenses
|
|
|
1,514 |
|
|
|
3,843 |
|
|
|
2,472 |
|
|
|
5,086 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense and other
|
|
|
(26 |
) |
|
|
(44 |
) |
|
|
(188 |
) |
|
|
(84 |
) |
|
Change in fair value of contingent payment obligations
|
|
|
1,723 |
|
|
|
2,304 |
|
|
|
1,326 |
|
|
|
(157 |
) |
|
Total other income (expense)
|
|
|
1,697 |
|
|
|
2,260 |
|
|
|
1,138 |
|
|
|
(241 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
148 |
|
|
$ |
(1,634 |
) |
|
$ |
(1,405 |
) |
|
$ |
(5,433 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.00 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.05 |
) |
|
Diluted
|
|
$ |
0.00 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.05 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
147,741 |
|
|
|
118,797 |
|
|
|
146,268 |
|
|
|
117,322 |
|
|
Diluted
|
|
|
168,772 |
|
|
|
118,797 |
|
|
|
146,268 |
|
|
|
117,322 |
|
ParkerVision, Inc.
Summary of Cash Flows
(unaudited)
| |
|
Six Months Ended
|
|
|
(in thousands)
|
|
June 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
Net cash used in operating activities
|
|
$ |
(1,737 |
) |
|
$ |
(2,969 |
) |
|
Net cash used in investing activities
|
|
|
- |
|
|
|
(43 |
) |
|
Net cash (used in) provided by financing activities
|
|
|
(122 |
) |
|
|
142 |
|
| |
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents
|
|
|
(1,859 |
) |
|
|
(2,870 |
) |
| |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents - beginning of period
|
|
|
4,360 |
|
|
|
4,918 |
|
| |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents - end of period
|
|
$ |
2,501 |
|
|
$ |
2,048 |
|
